Publication: 4717

Publication: 4717

Prognostic performance of Breast Cancer Index (BCI) in patients with early-stage HR+ HER2+ breast cancer treated with adjuvant trastuzumab: NCCTG N9831 (Alliance)

Google Scholar

Citation:

Meeting Instance:: SABCS 2025
Year:: 2025
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882, U24CA196171,

Corr. Author:
Authors:: Saranya Chumsri Emily Liu Kelly Edwards Yi Zhang Amanda K. L. Anderson Yujia Wen Ann Partridge Lisa Carey Karla Ballman Edith Perez Kai Treuner Matt Goetz E. Aubrey Thompson

Networks:: LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, PR028

Study: NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: